Arteris is down 52% from its June high, royalties grew 65%, and cash guidance is gone before November 5

Arteris▼−1.23% — Arteris, down 1.23 percent today, the network-on-chip IP licensor whose technology routes data inside the chips behind AI data centers, fell 52 percent from its June high of $45.33 to $20.59 by late October ¹. Nearly every line written about that slide traced back to one vendor's valuation model↗. The operating file behind the drop has gone unread. It contains a business compounding royalties at 65 percent, a Q3 revenue guide that barely moves, and a cash-flow disclosure the company just stopped providing ¹².

Two camps, one stock

The bulls hold a royalty story. Trailing-twelve-month variable royalties, payments that follow customers' chips into production, reached $8.6 million, up 65 percent ². Remaining performance obligations, contracted revenue not yet recognized, hit $135 million, up 36 percent ². Cash and short-term investments stood at $122.1 million at June 30 ².

The sceptics read the same quarter differently: Q3 revenue is guided to $24.0 to $25.0 million, a midpoint about 2 percent above the $24.1 million just printed, and quarterly free cash flow guidance has been discontinued↗ ². That means design wins are on the contract ledger but the chips are not yet shipping. The market has already voted with a 52 percent drawdown ¹.

What the operating file shows

Second-quarter revenue was $24.1 million, up 46 percent from $16.5 million a year earlier, and the year-on-year growth rate accelerated four quarters running, from 18.3 percent through 30 percent, 38.7 percent and 46.2 percent ²⁵. The sequential path was not a straight climb; revenue dipped slightly from $16.53 million in Q1 2025 to $16.5 million in Q2 2025 ⁵.

Losses widened too: the GAAP operating loss reached $13.9 million against $8.2 million a year before, and first-half free cash flow was just $1.3 million despite a strong $8.6 million second quarter ². The swings have a named cause: the $7.36 million negative free cash flow in Q1 2026 included roughly $3 million of Cycuity acquisition consideration and fees ⁴. Management flagged the rest: larger deal sizes create quarter-to-quarter cash flow swings, so it guides annually now ⁴. The full-year range, $5.0 to $9.0 million of free cash flow on $95.0 to $98.0 million of revenue, is the only yardstick left ².

The prints that cut both ways

Three signals inside the quarter point in opposite directions. Insider sales by the CEO, CFO and other executives totaled over $15 million, per one write-up; that source also carries an internally inconsistent revenue figure for Q2, so the sales total deserves its own check against Form 4 filings, the SEC disclosures that record insider trades, before any trade rests on it ¹.

Chief executive K. Charles Janac told investors that two-thirds of customer engagements are into AI chips, and that data center design cycles "rise quicker and they also die quicker" ⁴. Chief financial officer Nicholas Hawkins gave the timing answer in the same session: hyperscaler royalties take two to three years to flow through ⁴. Hawkins, who built the guidance record, retires August 31 ⁴.

The verdict arrives Thursday

Q3 results land November 5↗, the first print since quarterly cash guidance was withdrawn ³. Watch three lines: revenue inside the $24.0 to $25.0 million range, the non-GAAP operating loss against the guided $1.0 to $3.0 million, and royalty growth ².

If royalties keep compounding while revenue sits flat, the compounders were right and the market mispriced a timing gap. If royalties stall too, the design wins were recorded on contracts rather than collected from shipped chips, and $122.1 million of cash is the only floor left ². Either answer arrives in one print.